Literature DB >> 10592455

Growth hormone and fluid retention.

J Møller1, S Nielsen, T K Hansen.   

Abstract

A major side effect of growth hormone (GH) administration is fluid retention. Most data indicate that adult GH-deficient patients are dehydrated, i.e. they have low total body water, low extracellular water and low plasma volume. When GH substitution is initiated in these patients their body fluid compartments are restored to normal. The fluid retaining capacity of GH should therefore be regarded as a desirable physiological normalization of fluid homeostasis rather than an unpleasant side effect. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592455     DOI: 10.1159/000053173

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  7 in total

1.  Four-compartment cellular level body composition model: comparison of two approaches.

Authors:  Wei Shen; Marie-Pierre St-Onge; Angelo Pietrobelli; Jack Wang; ZiMian Wang; Stanley Heshka; Steven B Heymsfield
Journal:  Obes Res       Date:  2005-01

2.  Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk.

Authors:  Andrea S Cornford; Ariel L Barkan; Alexander Hinko; Jeffrey F Horowitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

3.  N-terminal pro-brain natriuretic peptide in newly diagnosed acromegaly.

Authors:  S Arikan; M Bahceci; A Tuzcu; D Gokalp
Journal:  J Endocrinol Invest       Date:  2010-09       Impact factor: 4.256

4.  OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients.

Authors:  Joel D Kopple; Alfred K Cheung; Jens Sandahl Christiansen; Christian Born Djurhuus; Meguid El Nahas; Bo Feldt-Rasmussen; Martin Lange; William E Mitch; Christoph Wanner; Jonas Wiedemann; T Alp Ikizler
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 5.  Growth hormone, IGF-I and insulin and their abuse in sport.

Authors:  R I G Holt; P H Sönksen
Journal:  Br J Pharmacol       Date:  2008-03-31       Impact factor: 8.739

Review 6.  Pathogenesis and prevalence of hypertension in acromegaly.

Authors:  M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

7.  Copeptin in Growth Hormone-Treated Patients.

Authors:  Anna Sjöström; Simona I Chisalita; Charlotte Höybye
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.